China Pharma Holdings (CPHI) Other Operating Expenses (2010 - 2026)

China Pharma Holdings has reported Other Operating Expenses for 17 years, with the latest figure at $92717.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 8.08% year-over-year to $92717.0; the trailing twelve-month figure through Mar 2026 stood at $381697.0 (down 25.77% YoY), and the FY2025 full-year result was $374768.0, down 29.89% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $92717.0, up from $82313.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $354261.0 in Q4 2022, with the low at $82313.0 in Q4 2025.
• Historically, Other Operating Expenses has averaged $161324.5 across 5 years, with a median of $134396.0 in 2023.
• Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 30.05% — and 2025, when it plunged 53.11%.
• China Pharma Holdings' Other Operating Expenses stood at $354261.0 in 2022, then fell by 24.35% to $267996.0 in 2023, then slumped by 34.5% to $175527.0 in 2024, then plunged by 53.11% to $82313.0 in 2025, then increased by 12.64% to $92717.0 in 2026.
• The last three Other Operating Expenses figures came in at $92717.0 (Q1 2026), $82313.0 (Q4 2025), and $103343.0 (Q3 2025), per Business Quant data.